Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-26 @ 2:23 AM
Study NCT ID:
NCT03787602
Status:
UNKNOWN
Last Update Posted:
2023-03-02
First Post:
2018-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
Sponsor:
Kartos Therapeutics, Inc.
Organization: